Dr Boreham's Crucible: Argenica Therapeutics
Argenica Therapeutics is aiming for a substantial slice of the stroke market, expected to be worth some US$180bn a year by 2030
Source: fnarena.com
📰 Prof Meloni News
Prof Meloni News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Prof Meloni. Real-time updates on events, politics, business and more.